Navidea Biopharmaceuticals (NAVB) Earnings
|
Expand Research on NAVB
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -80.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -1.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 11/10/25 |
Q325 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/18/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/13/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/27/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/15/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/14/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/19/25 |
Q225 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |


